| UniProt ID | KI18A_HUMAN | |
|---|---|---|
| UniProt AC | Q8NI77 | |
| Protein Name | Kinesin-like protein KIF18A | |
| Gene Name | KIF18A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 898 | |
| Subcellular Localization | Cell projection, ruffle. Cytoplasm. Nucleus. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. | |
| Protein Description | Microtubule-depolymerizing kinesin which plays a role in chromosome congression by reducing the amplitude of preanaphase oscillations and slowing poleward movement during anaphase, thus suppressing chromosome movements. May stabilize the CENPE-BUB1B complex at the kinetochores during early mitosis and maintains CENPE levels at kinetochores during chromosome congression.. | |
| Protein Sequence | MSVTEEDLCHHMKVVVRVRPENTKEKAAGFHKVVHVVDKHILVFDPKQEEVSFFHGKKTTNQNVIKKQNKDLKFVFDAVFDETSTQSEVFEHTTKPILRSFLNGYNCTVLAYGATGAGKTHTMLGSADEPGVMYLTMLHLYKCMDEIKEEKICSTAVSYLEVYNEQIRDLLVNSGPLAVREDTQKGVVVHGLTLHQPKSSEEILHLLDNGNKNRTQHPTDMNATSSRSHAVFQIYLRQQDKTASINQNVRIAKMSLIDLAGSERASTSGAKGTRFVEGTNINRSLLALGNVINALADSKRKNQHIPYRNSKLTRLLKDSLGGNCQTIMIAAVSPSSVFYDDTYNTLKYANRAKDIKSSLKSNVLNVNNHITQYVKICNEQKAEILLLKEKLKAYEEQKAFTNENDQAKLMISNPQEKEIERFQEILNCLFQNREEIRQEYLKLEMLLKENELKSFYQQQCHKQIEMMCSEDKVEKATGKRDHRLAMLKTRRSYLEKRREEELKQFDENTNWLHRVEKEMGLLSQNGHIPKELKKDLHCHHLHLQNKDLKAQIRHMMDLACLQEQQHRQTEAVLNALLPTLRKQYCTLKEAGLSNAAFESDFKEIEHLVERKKVVVWADQTAEQPKQNDLPGISVLMTFPQLGPVQPIPCCSSSGGTNLVKIPTEKRTRRKLMPSPLKGQHTLKSPPSQSVQLNDSLSKELQPIVYTPEDCRKAFQNPSTVTLMKPSSFTTSFQAISSNINSDNCLKMLCEVAIPHNRRKECGQEDLDSTFTICEDIKSSKCKLPEQESLPNDNKDILQRLDPSSFSTKHSMPVPSMVPSYMAMTTAAKRKRKLTSSTSNSSLTADVNSGFAKRVRQDNSSEKHLQENKPTMEHKRNICKINPSMVRKFGRNISKGNLR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSVTEEDLC ------CCCCHHHHH | 37.43 | 30108239 | |
| 4 | Phosphorylation | ----MSVTEEDLCHH ----CCCCHHHHHHC | 26.75 | 27732954 | |
| 24 | Sumoylation | RVRPENTKEKAAGFH EECCCCCHHHHHCCE | 69.65 | 25755297 | |
| 57 | Ubiquitination | EVSFFHGKKTTNQNV CEEEECCCCCCCCHH | 38.07 | 29967540 | |
| 57 | Acetylation | EVSFFHGKKTTNQNV CEEEECCCCCCCCHH | 38.07 | 25953088 | |
| 58 | Ubiquitination | VSFFHGKKTTNQNVI EEEECCCCCCCCHHH | 66.24 | 29967540 | |
| 126 | Phosphorylation | KTHTMLGSADEPGVM CCCCCCCCCCCCCHH | 28.69 | 22210691 | |
| 134 | Phosphorylation | ADEPGVMYLTMLHLY CCCCCHHHHHHHHHH | 9.16 | 22210691 | |
| 241 | Ubiquitination | IYLRQQDKTASINQN EEEECCCCCCCCCCC | 41.47 | - | |
| 242 | Phosphorylation | YLRQQDKTASINQNV EEECCCCCCCCCCCH | 33.65 | 19691289 | |
| 244 | Phosphorylation | RQQDKTASINQNVRI ECCCCCCCCCCCHHE | 27.57 | 19691289 | |
| 253 | Ubiquitination | NQNVRIAKMSLIDLA CCCHHEEEEEEEHHC | 27.01 | 29967540 | |
| 279 | Phosphorylation | GTRFVEGTNINRSLL CCCCCCCCCCCHHHH | 21.30 | 20068231 | |
| 284 | Phosphorylation | EGTNINRSLLALGNV CCCCCCHHHHHHHHH | 24.21 | 24719451 | |
| 298 | Phosphorylation | VINALADSKRKNQHI HHHHHHHCHHHCCCC | 28.84 | 20860994 | |
| 299 | Acetylation | INALADSKRKNQHIP HHHHHHCHHHCCCCC | 68.86 | 24431523 | |
| 299 | Ubiquitination | INALADSKRKNQHIP HHHHHHCHHHCCCCC | 68.86 | - | |
| 356 | Ubiquitination | ANRAKDIKSSLKSNV HHHHHHHHHHHHHCC | 44.09 | 29967540 | |
| 357 | Phosphorylation | NRAKDIKSSLKSNVL HHHHHHHHHHHHCCC | 41.03 | 22817900 | |
| 360 | Ubiquitination | KDIKSSLKSNVLNVN HHHHHHHHHCCCCCC | 41.76 | 29967540 | |
| 388 | Ubiquitination | KAEILLLKEKLKAYE HHHHHHHHHHHHHHH | 53.42 | 29967540 | |
| 398 | Sumoylation | LKAYEEQKAFTNEND HHHHHHHHHCCCCCH | 49.07 | - | |
| 398 | Ubiquitination | LKAYEEQKAFTNEND HHHHHHHHHCCCCCH | 49.07 | 29967540 | |
| 398 | Sumoylation | LKAYEEQKAFTNEND HHHHHHHHHCCCCCH | 49.07 | - | |
| 408 | Ubiquitination | TNENDQAKLMISNPQ CCCCHHHHHECCCHH | 32.71 | 29967540 | |
| 412 | Phosphorylation | DQAKLMISNPQEKEI HHHHHECCCHHHHHH | 28.61 | 25690035 | |
| 440 | Phosphorylation | REEIRQEYLKLEMLL HHHHHHHHHHHHHHH | 10.78 | 24043423 | |
| 453 | Ubiquitination | LLKENELKSFYQQQC HHHHHHHHHHHHHHH | 32.13 | 29967540 | |
| 503 | Ubiquitination | KRREEELKQFDENTN HHHHHHHHHHHHCCC | 52.80 | 29967540 | |
| 517 | Methylation | NWLHRVEKEMGLLSQ CHHHHHHHHHCHHHC | 50.58 | 23644510 | |
| 534 | Methylation | HIPKELKKDLHCHHL CCCHHHHHHHCCHHH | 77.48 | 23644510 | |
| 534 | Ubiquitination | HIPKELKKDLHCHHL CCCHHHHHHHCCHHH | 77.48 | 29967540 | |
| 546 | Ubiquitination | HHLHLQNKDLKAQIR HHHHCCCHHHHHHHH | 52.02 | 29967540 | |
| 549 | Ubiquitination | HLQNKDLKAQIRHMM HCCCHHHHHHHHHHH | 48.67 | 29967540 | |
| 588 | Ubiquitination | RKQYCTLKEAGLSNA HHHCCCHHHHCCCCH | 27.62 | 29967540 | |
| 602 | Ubiquitination | AAFESDFKEIEHLVE HHHHCCHHHHHHHHH | 63.87 | 29967540 | |
| 612 | Ubiquitination | EHLVERKKVVVWADQ HHHHHHCCEEEECCC | 46.62 | 29967540 | |
| 674 | Phosphorylation | TRRKLMPSPLKGQHT CCCCCCCCCCCCCCC | 28.97 | 30266825 | |
| 681 | Phosphorylation | SPLKGQHTLKSPPSQ CCCCCCCCCCCCCCC | 28.17 | 18669648 | |
| 683 | Sumoylation | LKGQHTLKSPPSQSV CCCCCCCCCCCCCCE | 63.17 | 28112733 | |
| 684 | Phosphorylation | KGQHTLKSPPSQSVQ CCCCCCCCCCCCCEE | 45.19 | 25159151 | |
| 687 | Phosphorylation | HTLKSPPSQSVQLND CCCCCCCCCCEECCC | 38.17 | 20873877 | |
| 689 | Phosphorylation | LKSPPSQSVQLNDSL CCCCCCCCEECCCCC | 19.03 | 20873877 | |
| 695 | Phosphorylation | QSVQLNDSLSKELQP CCEECCCCCCCCCCC | 33.21 | 25159151 | |
| 697 | Phosphorylation | VQLNDSLSKELQPIV EECCCCCCCCCCCCE | 28.21 | 25159151 | |
| 705 | Phosphorylation | KELQPIVYTPEDCRK CCCCCCEECHHHHHH | 19.80 | 30266825 | |
| 706 | Phosphorylation | ELQPIVYTPEDCRKA CCCCCEECHHHHHHH | 14.87 | 30266825 | |
| 712 | Ubiquitination | YTPEDCRKAFQNPST ECHHHHHHHHCCCCC | 60.94 | 29967540 | |
| 727 | Phosphorylation | VTLMKPSSFTTSFQA EEEECCCCCCCCHHH | 34.83 | 23403867 | |
| 729 | Phosphorylation | LMKPSSFTTSFQAIS EECCCCCCCCHHHHH | 24.39 | 23403867 | |
| 737 | Phosphorylation | TSFQAISSNINSDNC CCHHHHHCCCCCCHH | 35.30 | 23403867 | |
| 741 | Phosphorylation | AISSNINSDNCLKML HHHCCCCCCHHHHHH | 26.80 | 23403867 | |
| 769 | Phosphorylation | GQEDLDSTFTICEDI CCCCHHHCEEEEHHH | 25.19 | 22468782 | |
| 771 | Phosphorylation | EDLDSTFTICEDIKS CCHHHCEEEEHHHHH | 25.47 | 22468782 | |
| 788 | Phosphorylation | CKLPEQESLPNDNKD CCCCCHHCCCCCCHH | 49.15 | 28555341 | |
| 794 | Ubiquitination | ESLPNDNKDILQRLD HCCCCCCHHHHHHCC | 49.35 | 29967540 | |
| 794 | Sumoylation | ESLPNDNKDILQRLD HCCCCCCHHHHHHCC | 49.35 | - | |
| 794 | Sumoylation | ESLPNDNKDILQRLD HCCCCCCHHHHHHCC | 49.35 | 28112733 | |
| 810 | Phosphorylation | SSFSTKHSMPVPSMV CCCCCCCCCCCCCCC | 26.74 | 22210691 | |
| 815 | Phosphorylation | KHSMPVPSMVPSYMA CCCCCCCCCCHHHHH | 32.42 | 22210691 | |
| 819 | Phosphorylation | PVPSMVPSYMAMTTA CCCCCCHHHHHHHHH | 19.01 | 22210691 | |
| 825 | Phosphorylation | PSYMAMTTAAKRKRK HHHHHHHHHHHHHHC | 16.13 | 20068231 | |
| 834 | Phosphorylation | AKRKRKLTSSTSNSS HHHHHCCCCCCCCCC | 24.54 | 27273156 | |
| 835 | Phosphorylation | KRKRKLTSSTSNSSL HHHHCCCCCCCCCCC | 41.89 | 20068231 | |
| 836 | Phosphorylation | RKRKLTSSTSNSSLT HHHCCCCCCCCCCCC | 30.53 | 20068231 | |
| 837 | Phosphorylation | KRKLTSSTSNSSLTA HHCCCCCCCCCCCCE | 31.52 | 20068231 | |
| 838 | Phosphorylation | RKLTSSTSNSSLTAD HCCCCCCCCCCCCEE | 36.34 | 28112733 | |
| 840 | Phosphorylation | LTSSTSNSSLTADVN CCCCCCCCCCCEECC | 26.88 | 25159151 | |
| 841 | Phosphorylation | TSSTSNSSLTADVNS CCCCCCCCCCEECCC | 33.71 | 25159151 | |
| 843 | Phosphorylation | STSNSSLTADVNSGF CCCCCCCCEECCCCH | 23.82 | 20068231 | |
| 848 | Phosphorylation | SLTADVNSGFAKRVR CCCEECCCCHHHHHC | 34.83 | 20068231 | |
| 868 | Sumoylation | EKHLQENKPTMEHKR HHHHHHCCCCHHHHH | 40.90 | - | |
| 868 | Sumoylation | EKHLQENKPTMEHKR HHHHHHCCCCHHHHH | 40.90 | 28112733 | |
| 874 | Sumoylation | NKPTMEHKRNICKIN CCCCHHHHHHHHHCC | 33.56 | 28112733 | |
| 883 | O-linked_Glycosylation | NICKINPSMVRKFGR HHHHCCHHHHHHHCC | 25.97 | 30379171 | |
| 893 | Phosphorylation | RKFGRNISKGNLR-- HHHCCCCCCCCCC-- | 37.75 | 28857561 | |
| 894 | Sumoylation | KFGRNISKGNLR--- HHCCCCCCCCCC--- | 48.28 | - | |
| 894 | Sumoylation | KFGRNISKGNLR--- HHCCCCCCCCCC--- | 48.28 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of KI18A_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KI18A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KI18A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| XPO2_HUMAN | CSE1L | physical | 26496610 | |
| FOXM1_HUMAN | FOXM1 | physical | 26496610 | |
| PSMD5_HUMAN | PSMD5 | physical | 26496610 | |
| TFE2_HUMAN | TCF3 | physical | 26496610 | |
| ICAM5_HUMAN | ICAM5 | physical | 26496610 | |
| TTC3_HUMAN | TTC3 | physical | 26496610 | |
| MKNK1_HUMAN | MKNK1 | physical | 26496610 | |
| ITM2B_HUMAN | ITM2B | physical | 26496610 | |
| NCOR1_HUMAN | NCOR1 | physical | 26496610 | |
| KBP_HUMAN | KIAA1279 | physical | 26496610 | |
| RRP7A_HUMAN | RRP7A | physical | 26496610 | |
| KNL1_HUMAN | CASC5 | physical | 26496610 | |
| S39AA_HUMAN | SLC39A10 | physical | 26496610 | |
| GKAP1_HUMAN | GKAP1 | physical | 26496610 | |
| CR021_HUMAN | C18orf21 | physical | 26496610 | |
| EME1_HUMAN | EME1 | physical | 26496610 | |
| PP1R7_HUMAN | PPP1R7 | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-357, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244 AND SER-684, ANDMASS SPECTROMETRY. | |
| "Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-706, AND MASSSPECTROMETRY. | |